Frontlight ResearchEarly access
Trial site
Regionshospitalet Gødstrup
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Obesity2 trials
- Stroke2 trials
- Acute myeloid leukaemia1 trial
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Heart failure1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Multiple sclerosis1 trial
- Myelodysplastic syndromes1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Amgen2 trials
- Aarhus University Hospital1 trial
- Christoffer Johansen1 trial
- Copenhagen University Hospital, Rigshospitalet1 trial
- Eli Lilly and Company1 trial
- and 2 more
Running trials
Not yet recruiting
dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- Acute myeloid leukaemia1 recruiting
- Atrial fibrillation1 recruiting
- Chronic kidney disease1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Type 1 diabetes1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026